Serotonin Synthesis Inhibitor Helpful for Irritable Bowel Syndrome

Idsk -- BOSTON (EGMN) –LX1031, a novel, orally administered serotonin synthesis inhibitor, significantly improved overall irritable bowel syndrome symptoms in patients with nonconstipating IBS during a 4-week treatment period.